224 related articles for article (PubMed ID: 25461269)
1. H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential.
Gemici B; Elsheikh W; Feitosa KB; Costa SK; Muscara MN; Wallace JL
Nitric Oxide; 2015 Apr; 46():25-31. PubMed ID: 25461269
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide-based anti-inflammatory and chemopreventive therapies: an experimental approach.
Flannigan KL; Wallace JL
Curr Pharm Des; 2015; 21(21):3012-22. PubMed ID: 26004409
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
Gemici B; Wallace JL
Methods Enzymol; 2015; 555():169-93. PubMed ID: 25747480
[TBL] [Abstract][Full Text] [Related]
4. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
Elsheikh W; Blackler RW; Flannigan KL; Wallace JL
Nitric Oxide; 2014 Sep; 41():131-7. PubMed ID: 24747869
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide-releasing anti-inflammatory drugs.
Wallace JL
Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
[TBL] [Abstract][Full Text] [Related]
6. NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
Kashfi K; Chattopadhyay M; Kodela R
Redox Biol; 2015 Dec; 6():287-296. PubMed ID: 26298203
[TBL] [Abstract][Full Text] [Related]
7. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids.
Costa SKPF; Muscara MN; Allain T; Dallazen J; Gonzaga L; Buret AG; Vaughan DJ; Fowler CJ; de Nucci G; Wallace JL
Antioxid Redox Signal; 2020 Nov; 33(14):1003-1009. PubMed ID: 32064887
[No Abstract] [Full Text] [Related]
9. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.
Wallace JL; Blackler RW; Chan MV; Da Silva GJ; Elsheikh W; Flannigan KL; Gamaniek I; Manko A; Wang L; Motta JP; Buret AG
Antioxid Redox Signal; 2015 Feb; 22(5):398-410. PubMed ID: 24635322
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments.
Chan MV; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G467-73. PubMed ID: 23868410
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications.
Zhao Y; Biggs TD; Xian M
Chem Commun (Camb); 2014 Oct; 50(80):11788-805. PubMed ID: 25019301
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
Wallace JL; Caliendo G; Santagada V; Cirino G; Fiorucci S
Gastroenterology; 2007 Jan; 132(1):261-71. PubMed ID: 17241876
[TBL] [Abstract][Full Text] [Related]
13. ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.
De Cicco P; Panza E; Ercolano G; Armogida C; Sessa G; Pirozzi G; Cirino G; Wallace JL; Ianaro A
Pharmacol Res; 2016 Dec; 114():67-73. PubMed ID: 27777130
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer.
Ianaro A; Cirino G; Wallace JL
Pharmacol Res; 2016 Sep; 111():652-658. PubMed ID: 27475881
[TBL] [Abstract][Full Text] [Related]
15. Gaseous mediator-based anti-inflammatory drugs.
Sulaieva O; Wallace JL
Curr Opin Pharmacol; 2015 Dec; 25():1-6. PubMed ID: 26319186
[TBL] [Abstract][Full Text] [Related]
16. [Advances in hydrogen sulfide and hydrogen sulfide-releasing drugs].
Wang XL; Wang ZY; Guo XQ; Zhang YH; Yin J
Yao Xue Xue Bao; 2016 Apr; 51(4):507-16. PubMed ID: 29859518
[TBL] [Abstract][Full Text] [Related]
17. Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.
Paul-Clark M; Elsheikh W; Kirkby N; Chan M; Devchand P; Agbor TA; Flannigan KL; Cheadle C; Freydin M; Ianaro A; Mitchell JA; Wallace JL
PLoS One; 2016; 11(2):e0147289. PubMed ID: 26910063
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals.
Caliendo G; Cirino G; Santagada V; Wallace JL
J Med Chem; 2010 Sep; 53(17):6275-86. PubMed ID: 20462257
[No Abstract] [Full Text] [Related]
20. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras.
Kashfi K; Olson KR
Biochem Pharmacol; 2013 Mar; 85(5):689-703. PubMed ID: 23103569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
